Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Carbone

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural historyCarla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary CholangitisAngela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural historyCarla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.
JHEP Reports : Innovation in Hepatology|January 20, 2025
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitisAlessio Gerussi, Oliver Lester Saldanha, Giorgio Cazzaniga, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary CholangitisAngela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.
Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.
Pageof 19